Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.

Moreno-Torres V, Royuela A, Policarpo-Torres G, Paredes Ruiz D, Calabuig M, Sánchez Berná I, Capdevila Pons O, Colodro A, García-Morillo JS, Pallarés L, Trapiella L, Marin Ballvé A, Lavilla-Olleros C, Callejas-Rubio JL, Tornero F, Parra S, Rodríguez-Pintó I, Barbado Ajo J, Calero-Paniagua I, Rubio E, Argibay A, Gómez-Verdú JM, López-Dupla JM, Ripper CJ, Robles-Marhuenda A, Calvo-Begueria E, Fonseca E, González-García A, López-Aldabe K, Frutos-Pérez B, Hurtado-García R, Ponce A, Artinyan G, Crisolino Pozas AP, De Miguel-Campo B, Pousibet J, Espinosa G, Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI)

Open source

DOI: 10.1136/lupus-2026-001980
Published: 2026 Jul 20
Container: Lupus science & medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/lupus-2026-001980,
  title = {Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.},
  author = {Moreno-Torres V and Royuela A and Policarpo-Torres G and Paredes Ruiz D and Calabuig M and Sánchez Berná I and Capdevila Pons O and Colodro A and García-Morillo JS and Pallarés L and Trapiella L and Marin Ballvé A and Lavilla-Olleros C and Callejas-Rubio JL and Tornero F and Parra S and Rodríguez-Pintó I and Barbado Ajo J and Calero-Paniagua I and Rubio E and Argibay A and Gómez-Verdú JM and López-Dupla JM and Ripper CJ and Robles-Marhuenda A and Calvo-Begueria E and Fonseca E and González-García A and López-Aldabe K and Frutos-Pérez B and Hurtado-García R and Ponce A and Artinyan G and Crisolino Pozas AP and De Miguel-Campo B and Pousibet J and Espinosa G and Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI)},
  year = {2026},
  journal = {Lupus science \& medicine},
  doi = {10.1136/lupus-2026-001980},
  url = {https://doi.org/10.1136/lupus-2026-001980}
}

RIS

TY  - JOUR
TI  - Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.
AU  - Moreno-Torres V
AU  - Royuela A
AU  - Policarpo-Torres G
AU  - Paredes Ruiz D
AU  - Calabuig M
AU  - Sánchez Berná I
AU  - Capdevila Pons O
AU  - Colodro A
AU  - García-Morillo JS
AU  - Pallarés L
AU  - Trapiella L
AU  - Marin Ballvé A
AU  - Lavilla-Olleros C
AU  - Callejas-Rubio JL
AU  - Tornero F
AU  - Parra S
AU  - Rodríguez-Pintó I
AU  - Barbado Ajo J
AU  - Calero-Paniagua I
AU  - Rubio E
AU  - Argibay A
AU  - Gómez-Verdú JM
AU  - López-Dupla JM
AU  - Ripper CJ
AU  - Robles-Marhuenda A
AU  - Calvo-Begueria E
AU  - Fonseca E
AU  - González-García A
AU  - López-Aldabe K
AU  - Frutos-Pérez B
AU  - Hurtado-García R
AU  - Ponce A
AU  - Artinyan G
AU  - Crisolino Pozas AP
AU  - De Miguel-Campo B
AU  - Pousibet J
AU  - Espinosa G
AU  - Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI)
PY  - 2026
JO  - Lupus science & medicine
DO  - 10.1136/lupus-2026-001980
UR  - https://doi.org/10.1136/lupus-2026-001980
ER  -

APA

V, M., A, R., G, P., D, P. R., M, C., I, S. B., O, C. P., A, C., JS, G., L, P., L, T., A, M. B., C, L., JL, C., F, T., S, P., I, R., J, B. A., I, C., E, R., A, A., JM, G., JM, L., CJ, R., A, R., E, C., E, F., A, G., K, L., B, F., R, H., A, P., G, A., AP, C. P., B, D. M., J, P., G, E., & (SEMI), A. D. S. G. (. S. S. O. I. M. (2026). Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.. Lupus science & medicine. https://doi.org/10.1136/lupus-2026-001980

Source records

pubmed · retrieved 2026-09-25T19:30:47.653Z